Japanese wholesaler Toho builds up Chinese presence with joint venture
This article was originally published in Scrip
Toho Holdings has joined a number of other major Japanese pharma wholesalers moving into the Chinese market with the start of business operations at a joint venture in Wuhan, Hubei province.
You may also be interested in...
Join us for a quick audio roundup of major developments in the international biopharma industry over the past week, as covered by Scrip's global team.
Positive clinical results pave path forward for Japanese firm’s potential istradefylline successor.
Curon thinks tenalisib can offer a differentiated and safe new therapy for hematologic cancers such as multiple forms of lymphoma. Axis and PharmaEssentia team up on TCR therapy R&D in Taiwan.